| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
12,036 |
11,061 |
$2.59M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
14,546 |
13,569 |
$2.00M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
5,639 |
5,115 |
$589K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
3,067 |
2,935 |
$240K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
357 |
292 |
$146K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
1,725 |
1,123 |
$110K |
| 71046 |
Radiologic examination, chest; 2 views |
1,453 |
1,323 |
$89K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,849 |
2,426 |
$89K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
469 |
386 |
$84K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
299 |
271 |
$82K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
375 |
129 |
$59K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
566 |
528 |
$53K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,546 |
1,314 |
$50K |
| 59025 |
Fetal non-stress test |
343 |
226 |
$47K |
| 71045 |
Radiologic examination, chest; single view |
243 |
227 |
$15K |
| 70450 |
Computed tomography, head or brain; without contrast material |
121 |
109 |
$14K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
297 |
281 |
$14K |
| 80053 |
Comprehensive metabolic panel |
14,604 |
13,167 |
$12K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
340 |
323 |
$10K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
175 |
146 |
$9K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
325 |
311 |
$8K |
| 36415 |
Collection of venous blood by venipuncture |
4,287 |
3,716 |
$7K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
65 |
64 |
$7K |
| 0002A |
|
184 |
180 |
$6K |
| 0001A |
|
194 |
190 |
$6K |
| 84443 |
Thyroid stimulating hormone (TSH) |
364 |
353 |
$5K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
54 |
43 |
$5K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
16,688 |
14,801 |
$4K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
17 |
12 |
$2K |
| 80061 |
Lipid panel |
182 |
179 |
$2K |
| 0012A |
|
73 |
70 |
$2K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
74 |
69 |
$2K |
| 0011A |
|
71 |
68 |
$1K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
112 |
100 |
$925.02 |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
26 |
25 |
$840.59 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
3,043 |
2,633 |
$621.93 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
27 |
25 |
$605.86 |
| 85027 |
|
90 |
89 |
$508.82 |
| 87081 |
|
68 |
64 |
$471.09 |
| 87340 |
|
26 |
24 |
$245.89 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
12 |
12 |
$233.06 |
| 81001 |
|
2,364 |
2,179 |
$217.80 |
| 84703 |
|
2,420 |
2,228 |
$216.04 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
26 |
25 |
$191.10 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
639 |
523 |
$164.79 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
24 |
20 |
$161.46 |
| 86592 |
|
27 |
25 |
$106.72 |
| 94761 |
|
17 |
12 |
$35.67 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
498 |
439 |
$12.01 |
| 83690 |
|
2,192 |
1,938 |
$6.89 |
| 84484 |
|
1,373 |
1,156 |
$4.38 |
| 86140 |
|
814 |
711 |
$3.77 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,564 |
1,330 |
$2.36 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,248 |
1,131 |
$1.44 |
| 82150 |
|
12 |
12 |
$0.00 |
| A9270 |
Non-covered item or service |
2,388 |
1,906 |
$0.00 |
| 91301 |
|
150 |
105 |
$0.00 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
41 |
41 |
$0.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
125 |
102 |
$0.00 |
| 86901 |
|
31 |
27 |
$0.00 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
235 |
222 |
$0.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
29 |
24 |
$0.00 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
256 |
237 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
38 |
37 |
$0.00 |
| 83605 |
|
85 |
66 |
$0.00 |
| 83735 |
|
293 |
244 |
$0.00 |
| 96376 |
|
76 |
43 |
$0.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
15 |
13 |
$0.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
39 |
38 |
$0.00 |
| 85379 |
|
28 |
25 |
$0.00 |
| 86850 |
|
13 |
13 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
15 |
14 |
$0.00 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
2,698 |
2,369 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
457 |
401 |
$0.00 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
531 |
510 |
$0.00 |
| J2274 |
Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg |
191 |
147 |
$0.00 |
| 87631 |
|
14 |
14 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
881 |
749 |
$0.00 |
| 87634 |
|
100 |
97 |
$0.00 |
| 73562 |
|
13 |
12 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
62 |
52 |
$0.00 |
| 84702 |
|
89 |
74 |
$0.00 |
| 81003 |
|
182 |
165 |
$0.00 |
| A4216 |
Sterile water, saline and/or dextrose, diluent/flush, 10 ml |
131 |
115 |
$0.00 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
96 |
84 |
$0.00 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
78 |
76 |
$0.00 |
| 73610 |
|
32 |
31 |
$0.00 |
| 73630 |
|
16 |
15 |
$0.00 |
| 91300 |
|
376 |
198 |
$0.00 |